Finance

Beta
Lists
SPMA:IDX
Suparma Tbk PT
IDR 196.00
-1.01%
(-2.00) 1D
Jun 5, 4:00:05 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for SPMA...
Open
IDR 200
High
IDR 202
Low
IDR 196
Mkt. cap
803.66B
Avg. vol.
490.56K
Volume
349.80K
P/E ratio
7.78
52-wk high
IDR 338
52-wk low
IDR 191
EPS
IDR 25
Shares outstanding
4.10B
No. of employees
833
Open
IDR 200
High
IDR 202
Low
IDR 196
Mkt. cap
803.66B
Avg. vol.
490.56K
Volume
349.80K
P/E ratio
7.78
52-wk high
IDR 338
52-wk low
IDR 191
EPS
IDR 25
Shares outstanding
4.10B
No. of employees
833
News stories
From sources across the web
Profile
Suparma is an Indonesian pulp and paper company based in Surabaya, East Java. Suparma was founded in 1976 by Welly. Wikipedia
About Suparma Tbk PT
CEO-
Employees833
FoundedAug 25, 1976
Headquarters-
SectorPaper
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
651.56B
701.68B
750.69B
653.03B
Cost of goods sold
556.52B
593.99B
630.34B
560.07B
Cost of revenue
556.52B
593.99B
630.34B
560.07B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56.17B
49.53B
54.36B
64.59B
Operating expense
56.60B
53.53B
57.27B
64.59B
Total operating expenses
613.12B
647.52B
687.61B
624.66B
Operating income
38.43B
54.16B
63.08B
28.37B
Other non operating income
-1.25B
140.14M
-383.44M
-193.45M
EBT including unusual items
50.73B
21.23B
48.25B
11.69B
EBT excluding unusual items
49.49B
22.48B
48.25B
11.69B
Income tax expense
10.84B
5.87B
10.44B
1.45B
Effective tax rate
21.38%
27.64%
21.65%
12.43%
Other operating expenses
426.43M
4.00B
2.91B
-
Net income
39.88B
15.36B
37.81B
10.23B
Net profit margin
6.12%
2.19%
5.04%
1.57%
Earnings per share
-
-
-
-
Interest and investment income
1.33B
1.86B
1.11B
971.36M
Interest expense
-7.19B
-10.29B
-11.27B
-7.30B
Net interest expenses
-5.86B
-8.43B
-10.16B
-6.32B
Depreciation and amortization charges
-
-
-
-
EBITDA
68.64B
104.52B
74.13B
57.79B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more